Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Wiemer

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Neural Computation|June 14, 2003
The time-organized map algorithm: extending the self-organizing map to spatiotemporal signalsJan C Wiemer
Pathology, Research and Practice|July 9, 2004
Bioinformatics in proteomics: application, terminology, and pitfallsJan C Wiemer, Alexander Prokudin
ESC Heart Failure|August 27, 2022
Performance evaluation of a new prognostic-efficacy-combination design in the context of telemedical interventionsMareen Pigorsch, Martin Möckel, Stefan Gehrig, et al.
Annals of Intensive Care|June 6, 2018
Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shockAndreas Hohn, Nina Balfer, Bernhard Heising, et al.
ESC Heart Failure|April 19, 2018
Early identification of acute heart failure at the time of presentation: do natriuretic peptides make the difference?Martin Möckel, Stephan von Haehling, Jörn O Vollert, et al.
Plos One|November 26, 2009
Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgeryDavid M Mutch, Jens C Fuhrmann, Dietrich Rein, et al.
Journal of Proteome Research|December 15, 2004
Identification of gastric cancer patients by serum protein profilingMatthias P A Ebert, Jörn Meuer, Jan C Wiemer, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 22, 2017
Rationale and design of the IMPACT EU-trial: improve management of heart failure with procalcitonin biomarkers in cardiology (BIC)-18Martin Möckel, Anna Slagman, Jörn Ole Vollert, et al.
European Journal of Heart Failure|May 27, 2019
Biomarker guidance allows a more personalized allocation of patients for remote patient management in heart failure: results from the TIM-HF2 trialMartin Möckel, Kerstin Koehler, Stefan D Anker, et al.
European Journal of Heart Failure|December 14, 2019
Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACT EU Biomarkers in Cardiology (BIC) 18Martin Möckel, Rudolf A de Boer, Anna Christine Slagman, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Neural Computation|June 14, 2003
The time-organized map algorithm: extending the self-organizing map to spatiotemporal signalsJan C Wiemer
Pathology, Research and Practice|July 9, 2004
Bioinformatics in proteomics: application, terminology, and pitfallsJan C Wiemer, Alexander Prokudin
ESC Heart Failure|August 27, 2022
Performance evaluation of a new prognostic-efficacy-combination design in the context of telemedical interventionsMareen Pigorsch, Martin Möckel, Stefan Gehrig, et al.
Annals of Intensive Care|June 6, 2018
Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shockAndreas Hohn, Nina Balfer, Bernhard Heising, et al.
ESC Heart Failure|April 19, 2018
Early identification of acute heart failure at the time of presentation: do natriuretic peptides make the difference?Martin Möckel, Stephan von Haehling, Jörn O Vollert, et al.
Plos One|November 26, 2009
Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgeryDavid M Mutch, Jens C Fuhrmann, Dietrich Rein, et al.
Journal of Proteome Research|December 15, 2004
Identification of gastric cancer patients by serum protein profilingMatthias P A Ebert, Jörn Meuer, Jan C Wiemer, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 22, 2017
Rationale and design of the IMPACT EU-trial: improve management of heart failure with procalcitonin biomarkers in cardiology (BIC)-18Martin Möckel, Anna Slagman, Jörn Ole Vollert, et al.
European Journal of Heart Failure|May 27, 2019
Biomarker guidance allows a more personalized allocation of patients for remote patient management in heart failure: results from the TIM-HF2 trialMartin Möckel, Kerstin Koehler, Stefan D Anker, et al.
European Journal of Heart Failure|December 14, 2019
Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACT EU Biomarkers in Cardiology (BIC) 18Martin Möckel, Rudolf A de Boer, Anna Christine Slagman, et al.
Pageof 2